[1]韩慧慧,马娜,张云清,等.杞菊地黄汤联合诺和锐特充治疗妊娠期糖尿病41例[J].西部中医药,2020,33(04):106-108.[doi:10.12174/j.issn.1004-6852.2020.04.32]
　HAN Huihui,MA Na,ZHANG Yunqing,et al.Qiju Dihuang Tang Combined with Insulin Aspart in Treating 41 Cases of Gestational Diabetes Mellitus[J].Western Journal of Traditional Chinese Medicine,2020,33(04):106-108.[doi:10.12174/j.issn.1004-6852.2020.04.32]
点击复制

杞菊地黄汤联合诺和锐特充治疗妊娠期糖尿病41例
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年04期
页码:
106-108
栏目:
出版日期:
2020-04-15

文章信息/Info

Title:
Qiju Dihuang Tang Combined with Insulin Aspart in Treating 41 Cases of Gestational Diabetes Mellitus
文章编号:
1004-6852(2020)04-0106-03
作者:
韩慧慧，马娜，张云清，刘运磊，高霞
延安大学附属医院，陕西 延安 716000
Author(s):
HAN Huihui, MA Na△, ZHANG Yunqing, LIU Yunlei, GAO Xia
Yan′an University Affiliated Hospital, Yan′an 716000, China
关键词:
妊娠期糖尿病; 杞菊地黄汤; 诺和锐特充; 胰岛β细胞功能; 妊娠结局
Keywords:
gestational diabetes mellitus;  Qiju Dihuang Tang;  insulin aspart;  islet β-cell function; pregnancy outcome
DOI:
10.12174/j.issn.1004-6852.2020.04.32
文献标志码:
B
摘要:
目的：观察杞菊地黄汤联合诺和锐特充治疗妊娠期糖尿病的临床疗效。方法：将82例妊娠期糖尿病患者随机分为两组，每组41例。对照组皮下注射诺和锐特充，观察组在此基础上服用杞菊地黄汤。治疗一个月后，比较两组患者胰岛β细胞功能(HOMA-β)和妊娠结局。结果：总有效率观察组为92.68%（38/41），对照组为78.05%（32/41），2组比较差异有统计学意义(P＜0.05)。治疗后，两组餐后2 h血糖及空腹血糖均明显降低，HOMA-β明显升高，组内比较差异均有统计学意义(P＜0.05)，组间比较差异也有统计学意义(P＜0.05)；剖宫产率、并发症发生率观察组分别为34.15%（14/41）、14.6%（6/41），对照组分别为60.98%（25/41）、41.46%（17/41），2组比较差异均有统计学意义(P＜0.05)。不良新生儿结局发生率观察组为21.95%（9/41），对照组为65.85%（27/41），2组比较，差异有统计学意义(P＜0.05)。结论：杞菊地黄汤联合诺和锐特充治疗妊娠期糖尿病患者具有较为满意的疗效，可以有效改善其HOMA-β水平和妊娠结局。
Abstract:
Objective: To observe clinical effects of Qiju Dihuang Tang and insulin aspart in the treatment for gestational diabetes mellitus (GDM). Methods: All 82 GDM patients were randomized into two groups, 41 cases each group. The control group accepted subcutaneous injection of insulin aspart, and the observation group took Qiju Dihuang Tang orally. To compare islet β-cell function (HOMA-β) and pregnancy outcome between both groups. Results: Total effective rate of the observation group was 92.68% (38/41), higher than 78.05% (32/41) of the control group, and the difference had statistical meaning between both groups (P＜0.05). After treating, 2-hour postprandial blood glucose and fasting blood glucose reduced notably in both groups, HOMA-β rose notably, the difference showed statistical meaning within the groups (P＜0.05), the difference was statistically significant between both groups (P＜0.05), cesarean section rate and the complication incidence of the observation group were 34.15% (14/41) and 14.6% (6/41), lower than 60.98% (25/41) and 41.46% (17/41) of the control group, and the difference presented statistical meaning (P＜0.05). The incidence of adverse neonatal outcome in the observation group was 21.95% (9/41), lower than 65.85% (27/41) of the control group, and the difference showed statistical meaning between both groups (P＜0.05). Conclusion: Qiju Dihuang Tang and insulin aspart possess satisfactory clinical effects in the treatment for GDM, it could effectively improve HOMA-β level and pregnancy outcome.

相似文献/References:

[1]张学平,赵慧民,汤瑞霞,等.参芪地黄降糖颗粒治疗妊娠期糖尿病临床观察[J].西部中医药,2015,28(05):92.
[2]郭麦荣,李晶△.中西医结合治疗肝肾阴虚型高血压40例[J].西部中医药,2015,28(06):112.[doi:2015/6/16 0:00:00]
[3]付继锋,王琪,石玉芬△.诺和锐特充联合黄芪四君子汤治疗妊娠期糖尿病110例[J].西部中医药,2018,31(06):91.
　FU Jifeng,WANG Qi,SHI Yufen.Insulin Aspart Combined with HuangQi SiJunZi Decoction in Treating 110 Patients with Gestational Diabetes[J].Western Journal of Traditional Chinese Medicine,2018,31(04):91.
[4]丁静丽,蒋盘华.基于个案管理的个性化随访对妊娠期糖尿病患者生活质量和身体意象的影响[J].西部中医药,2019,32(07):64.
　DING Jingli,JIANG Panhua.Effects of Personalized Follow-up Based on Case Management on Quality of Life and Body Image in Patients with Gestational Diabetes Mellitus[J].Western Journal of Traditional Chinese Medicine,2019,32(04):64.

备注/Memo

备注/Memo:
收稿日期：2019-06-19*基金项目：陕西省教育厅科学研究项目（12JK0717）。作者简介：韩慧慧(1983—)，女，主管护师。研究方向：产科疾病的诊治。△通讯作者：马娜(1979—)，主管护师。研究方向：产科疾病的临床诊治。
更新日期/Last Update: 2020-04-15